USD 25.72
(1.94%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 201.74 Million USD | 35.33% |
2023 | 171.64 Million USD | 30.19% |
2022 | 131.84 Million USD | 36.92% |
2021 | 96.29 Million USD | 20.27% |
2020 | 80.06 Million USD | 27.3% |
2019 | 62.89 Million USD | 25.62% |
2018 | 50.06 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q4 | 54.77 Million USD | -9.73% |
2024 FY | 201.74 Million USD | 17.54% |
2024 Q3 | 60.68 Million USD | 9.28% |
2024 Q1 | 52.84 Million USD | 8.69% |
2024 Q2 | 55.52 Million USD | 5.07% |
2023 Q3 | 45.77 Million USD | 13.18% |
2023 Q2 | 40.44 Million USD | 9.86% |
2023 FY | 171.64 Million USD | 30.19% |
2023 Q1 | 36.81 Million USD | 3.21% |
2023 Q4 | 48.62 Million USD | 6.23% |
2022 Q2 | 31.32 Million USD | 4.31% |
2022 Q1 | 30.03 Million USD | 11.13% |
2022 Q3 | 34.82 Million USD | 11.16% |
2022 FY | 131.84 Million USD | 36.92% |
2022 Q4 | 35.66 Million USD | 2.42% |
2021 Q2 | 22.99 Million USD | 5.4% |
2021 Q1 | 21.81 Million USD | 0.79% |
2021 Q3 | 24.46 Million USD | 6.4% |
2021 Q4 | 27.02 Million USD | 10.47% |
2021 FY | 96.29 Million USD | 20.27% |
2020 FY | 80.06 Million USD | 27.3% |
2020 Q3 | 21.55 Million USD | 10.5% |
2020 Q4 | 21.64 Million USD | 0.41% |
2020 Q2 | 19.5 Million USD | 12.33% |
2020 Q1 | 17.36 Million USD | 5.71% |
2019 FY | 62.89 Million USD | 25.62% |
2019 Q4 | 16.42 Million USD | 5.58% |
2019 Q1 | 15.05 Million USD | 0.0% |
2019 Q2 | 15.84 Million USD | 5.25% |
2019 Q3 | 15.55 Million USD | -1.83% |
2018 FY | 50.06 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Well Corporation | 94.76 Million USD | -112.901% |
Doximity, Inc. | 424.75 Million USD | 52.503% |
Evolent Health, Inc. | 460.47 Million USD | 56.187% |
MultiPlan Corporation | 306.03 Million USD | 34.079% |
Teladoc Health, Inc. | 1.84 Billion USD | 89.05% |
Veeva Systems Inc. | 1.68 Billion USD | 88.037% |